IRIS
BONAVITA, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.825
NA - Nord America 7.395
AS - Asia 6.419
SA - Sud America 1.100
Continente sconosciuto - Info sul continente non disponibili 502
AF - Africa 99
OC - Oceania 17
AN - Antartide 1
Totale 30.358
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 9.545
US - Stati Uniti d'America 7.236
SG - Singapore 2.207
CN - Cina 1.493
IT - Italia 1.420
IE - Irlanda 1.397
HK - Hong Kong 990
BR - Brasile 900
VN - Vietnam 734
GB - Regno Unito 596
DE - Germania 513
UA - Ucraina 425
KR - Corea 271
IN - India 211
SE - Svezia 170
FR - Francia 159
TR - Turchia 149
FI - Finlandia 142
JP - Giappone 125
GR - Grecia 121
AT - Austria 104
AR - Argentina 77
CA - Canada 61
MX - Messico 59
BD - Bangladesh 51
NL - Olanda 51
BE - Belgio 40
EC - Ecuador 32
PL - Polonia 30
CO - Colombia 29
IQ - Iraq 26
ES - Italia 24
ID - Indonesia 22
ZA - Sudafrica 22
EG - Egitto 19
PK - Pakistan 19
MA - Marocco 18
VE - Venezuela 18
CZ - Repubblica Ceca 17
AU - Australia 15
SA - Arabia Saudita 14
PY - Paraguay 13
CH - Svizzera 12
IL - Israele 12
CL - Cile 11
IR - Iran 11
PE - Perù 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 9
TN - Tunisia 9
KE - Kenya 8
CR - Costa Rica 7
KZ - Kazakistan 7
LT - Lituania 7
RS - Serbia 7
TH - Thailandia 7
UY - Uruguay 7
DZ - Algeria 6
JM - Giamaica 6
JO - Giordania 6
PA - Panama 6
PH - Filippine 6
RO - Romania 6
AZ - Azerbaigian 5
EU - Europa 5
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
HU - Ungheria 4
IS - Islanda 4
KG - Kirghizistan 4
LU - Lussemburgo 4
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
NI - Nicaragua 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
CY - Cipro 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
KW - Kuwait 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 29.842
Salva come PNG Salva come JPEG
Città #
Moscow 3.362
Dublin 1.395
San Jose 1.091
Hong Kong 972
Santa Clara 945
Singapore 875
Jacksonville 640
Chandler 583
Ashburn 387
Ho Chi Minh City 266
Seoul 265
Hefei 260
Beijing 210
Princeton 201
Dallas 172
Hanoi 168
Ann Arbor 160
Roxbury 159
Medford 147
Bremen 142
New York 134
Bengaluru 127
Boardman 118
Naples 115
Caserta 114
The Dalles 107
Council Bluffs 98
Los Angeles 98
Munich 91
Vienna 84
Milan 82
São Paulo 73
Cambridge 71
Rome 65
Wilmington 64
Memphis 63
Woodbridge 56
San Mateo 55
Des Moines 45
Da Nang 44
Nanjing 43
Brussels 39
Norwalk 37
Nuremberg 34
Napoli 33
Orem 33
Atlanta 29
Jinan 29
Redhill 27
Warsaw 27
Belo Horizonte 26
Haiphong 26
San Francisco 25
Shenyang 24
Tokyo 24
Chicago 23
Helsinki 23
London 23
Mexico City 22
Rio de Janeiro 22
Brasília 21
Frankfurt am Main 21
Guangzhou 21
Redwood City 20
Tianjin 20
Denver 19
Houston 19
Stockholm 19
Buffalo 18
Falkenstein 18
Chennai 17
Montreal 17
Phoenix 17
Brooklyn 16
Turin 16
Boston 15
Toronto 15
Aversa 14
Hebei 14
Shanghai 14
Curitiba 13
Genoa 13
Hangzhou 13
Lappeenranta 13
Mountain View 13
Nanchang 13
Turku 13
Amsterdam 12
Biên Hòa 12
Campinas 12
Hải Dương 12
Lanzhou 12
Padova 12
Porto Alegre 12
Thái Bình 12
Bologna 11
Brno 11
Düsseldorf 11
Johannesburg 11
Manchester 11
Totale 15.266
Salva come PNG Salva come JPEG
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 667
Spazi di Virchow Robin e sclerosi multipla: studio con risonanza magnetica ad Alto Campo 3 Tesla 274
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 211
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 209
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 199
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 195
Advantages of QBI in TBSS analyses. 187
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 181
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 179
Preliminary data from a study on clinical and neuroradiological correlations between cerebral microbleeds and different subtypes of mild cognitive impairment 179
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 177
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 176
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 173
Atypical Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient With Improving Symptoms After Immunocompetence Recovery 172
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 169
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 169
Telemedicine application to headache: a critical review 169
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 166
Repetitive Transcranial Magnetic Stimulation (rTMS) of Dorsolateral Prefrontal Cortex May Influence Semantic Fluency and Functional Connectivity in Fronto-Parietal Network in Mild Cognitive Impairment (MCI) 166
Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies 165
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 160
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 159
Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: An Italian multi-center study using the Beck Depression Inventory 158
An exploration of anger phenomenology in multiple sclerosis 157
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 155
Aspetti neuroradiologici inusuali in un caso di leucoencefalite multifocale progressiva in paziente non HIV positivo 154
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells 153
Is the pathology of posterior cortical atrophy clinically predictable? 152
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 151
Long-Term Neuromodulatory Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Plasmatic Matrix Metalloproteinases (MMPs) Levels and Visuospatial Abilities in Mild Cognitive Impairment (MCI) 150
Disease Reactivation in Secondary Progressive Multiple Sclerosis Patients Switching from Fingolimod to Siponimod: A Case Series 149
Apparently isolated CNS involvement in Erdheim-Chester disease: Case report 149
Il Ruolo della RM nella definizione morfologica dell'invecchiamento cerebrale. 148
Fake news, influencers and health-related professional participation on the Web: A pilot study on a social-network of people with Multiple Sclerosis 148
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 147
Between-sex variability of resting state functional brain networks in amyotrophic lateral sclerosis (ALS) 147
Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study 146
Assessment of Multiple Sclerosis Disability Progression Using a Wearable Biosensor: A Pilot Study 143
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 142
Digital Health in Diabetes Care: A Narrative Review from Monitoring to the Management of Systemic and Neurologic Complications 141
Chronic acquired hepatocerebral degeneration: a case report. 141
Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic 141
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 140
Cd19 cell count at baseline predicts b cell repopulation at 6 and 12 months in multiple sclerosis patients treated with ocrelizumab 140
Whole-brain propagation delays in multiple sclerosis, a combined tractography - magnetoencephalography study 139
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 139
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 139
Repetitive Transcranial Magnetic Stimulation (rTMS) in Mild Cognitive Impairment: Effects on Cognitive Functions-A Systematic Review 138
Clinically Manifest Infections Do Not Increase the Relapse Risk in People with Multiple Sclerosis Treated with Disease-Modifying Therapies: A Prospective Study 138
e-Health and multiple sclerosis: An update 138
Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis 138
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 137
Treatment of multiple sclerosis with interferon beta in clinical practice: 2-year follow-up data from the South Italy Mobile MRI Project. 137
Association between relapses, stress, and depression in people with multiple sclerosis during the COVID-19 pandemic 137
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study. 136
BMI influences CD20 kinetics in multiple sclerosis patients treated with ocrelizumab 135
Optimal retreatment schedule of rituximab for neuromyelitis optica spectrum disorder: A systematic review 132
The role of diet in multiple sclerosis: A review 132
Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis 131
Cognitive reserve predicts long-term cognitive trajectories in relapsing-remitting multiple sclerosis 131
Disability assessment using Google Maps 131
Apolipoprotein E genotype does not influence the progression of multiple sclerosis 130
Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail 130
A real-world study of alemtuzumab in a cohort of Italian patients 130
Signs and symptoms of COVID-19 in patients with multiple sclerosis 129
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate 129
Proton spectroscopic imaging - Principles and clinical applications in neurology 128
Anti-GM1 ganglioside antibodies in Parkinson's disease 128
Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis 127
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey 127
Effectiveness and Safety of CGRP-mAbs in Menstrual-Related Migraine: A Real-World Experience 127
La terapia della sclerosi multipla 126
Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 tesla in the delineation of glioblastomas: Preliminary results 125
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 125
Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition 125
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 124
Immunomodulatory effects of ocrelizumab and candidate biomarkers for monitoring treatment response in multiple sclerosis 124
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 124
Pelvic Floor Dysfunctions and Their Rehabilitation in Multiple Sclerosis 123
MAlattie infettive (meningiti, encefaliti, infezione da HIV, encefalopatie spongiformi) 122
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 122
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study 122
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 121
Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach. 120
Right phrenic nerve palsy following transcatheter radiofrequency current atrial fibrillation ablation: Case report 120
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 120
A disease in the age of the web: How to help people with Multiple Sclerosis in social media interaction. 120
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity 120
Viral pericarditis following ocrelizumab in a multiple sclerosis patient 119
Pain, quality of life, and religiosity in people with multiple sclerosis 119
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 118
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 118
MRI and steroid-responsive encephalopathy associated with autoimmune thyroiditis: first report of conus medullaris involvement and literature review of the known neuroimaging profiles 118
Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent 118
Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. 118
Social Media and Multiple Sclerosis in the Posttruth Age. 118
Sistema somato-sensitivo 117
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 117
Clinical implications for the association of psoriasis and multiple sclerosis: an observational study 116
Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis 116
Totale 14.842
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.620
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.379 0 53 37 54 428 45 35 46 62 98 95 426
2022/20232.619 280 51 33 175 314 165 4 162 1.276 29 59 71
2023/20241.486 109 46 87 135 411 116 115 38 32 37 107 253
2024/20254.071 18 37 36 157 643 527 488 336 620 591 361 257
2025/202617.016 608 892 941 810 1.421 8.867 1.066 928 573 396 345 169
2026/2027324 111 213 0 0 0 0 0 0 0 0 0 0
Totale 30.358